Log in to save to my catalogue

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity t...

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity t...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2237860369

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

The efficacy of programmed cell death protein 1 (PD-1) blockade in metastatic triple-negative breast cancer (TNBC) is low
1

5
, highlighting a need for strategies that render the tumor microenvironment more sensitive to PD-1 blockade. Preclinical research has suggested immunomodulatory properties for chemotherapy and irradiation
...

Alternative Titles

Full title

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2237860369

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2237860369

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/s41591-019-0432-4

How to access this item